GCP Applied Technologies Reports Third Quarter 2016 Results
Nov 09, 2016 11:00 am UTC| Business
Net sales down 12.1%; Net Sales, Constant Currency excluding Venezuela* down 0.7%Net income of $21.3 million; Adjusted EBIT Margin excluding Venezuela* up 40 bpsDiluted EPS of $0.30; Adjusted EPS* of $0.35Year-to-date net...
HMS Holdings Corp. Reports Third Quarter 2016 Results
Nov 09, 2016 11:00 am UTC| Business
Q3 GAAP EPS of $0.16 Per Diluted Share and Adjusted EPS of $0.24 Per Diluted ShareCommercial Health Plan Revenue Was a Record $59.2 million for Q3 and Up 17.9% YTDAcquisition of Web-based Care Management Platform, Essette,...
MySize Inc. Upgrades SizeUp App to Include “Measurement from the Air” Capability
Nov 09, 2016 11:00 am UTC| Business
AIRPORT CITY, Israel, Nov. 09, 2016 -- MySize Inc. (the “Company”) (NASDAQ:MYSZ) (TASE:MYSZ), developer of unique measurement technology applications for Smartphones, announced today that its SizeUp DIY measurement app...
Nov 09, 2016 11:00 am UTC| Business
BETHLEHEM, Pa., Nov. 09, 2016 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will...
Christopher J. Ryan, of Giarmarco, Mullins & Horton, P.C., Named as a 2016 Rising Star
Nov 09, 2016 11:00 am UTC| Business
TROY, Mich., Nov. 09, 2016 -- Christopher J. Ryan has been named as a 2016 Rising Star. Mr. Ryan is a shareholder in the firm’s litigation practice group. He practices many types of litigation, but focuses his...
Orion Marine Group Announces a Contract Award of Approximately $19 million
Nov 09, 2016 10:00 am UTC| Business
HOUSTON, Nov. 09, 2016 -- Orion Group Holdings, Inc. (NYSE:ORN) (the "Company") a leading specialty construction company, today announced a contract award of approximately $19 million. The Company’s Heavy Civil Marine...
Affimed to Present at the Jefferies 2016 London Healthcare Conference
Nov 09, 2016 10:00 am UTC| Business
HEIDELBERG, Germany, Nov. 09, 2016 -- Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi...